Simponi Class Action
Today more and more people are diagnosed with some type of autoimmune condition. One of the ones that we see mentioned on television, and in the news a lot more often is the condition known as rheumatoid arthritis.
One of the drugs that are prescribed to treat this condition is called Simponi, and if this is a drug that was prescribed for you to use in the treatment of rheumatoid arthritis, then we have some information that you may find pertinent.
What is Simponi?
Simponi-(golimumab) was originally sold by a company called Centocor Biotech, Inc. Today the company is known as Janssen Biotech, Inc. whose parent company happens to be Johnson and Johnson.
Simponi is prescribed to adults who suffer from rheumatoid arthritis, and it works by binding to TNF-alpha cells, preventing these cells that occur naturally in our bodies from attaching to immune cells, preventing an autoimmune response. The drug is administered to a patient monthly via injection.
Associated Side Effects
Unfortunately there are several degrees of side effects that are associated with taking this drug. Some of these effects include:
- Stomach pain
- Severe headaches
- Bloody stools
- Tingling sensations in the hands
- Irregular heartbeat
- Changes in vision
- Unexplained pain in joints
There is also the possibility of a person having a seizure or chest pain while taking this drug. Other side effects may include itching, redness and swelling at the injection site.
There is also the possibility of an allergic reaction to taking this drug. If a patient experiences any of the following symptoms they should seek immediate medical attention:
- Swelling of the face, tongue, throat
- Breathing problems
In April of 2009 the FDA approved Simponi for treatment in adults suffering from rheumatoid arthritis as well as another autoimmune condition called psoriatic arthritis.
Since that time the drug and its manufacturer have faced a few issues due to complaints from people who were prescribed the drug, as well as a denial by the FDA in 2011 rejecting the drug for expanded use in treating RA symptoms.
It was reported that in response to this decision, Johnson and Johnson requested a meeting with the FDA to discuss their application for the expansion of the drug’s use. The FDA’s Jerome Boscia in a statement said that they (the FDA) looked forward to working hand in hand with Johnson and Johnson in the matter.
In May of 2009, the FDA issued a warning to healthcare professionals about the dangers associated with TNF-Alpha blockers such as Simponi. In their statement, the FDA stated that there is not a serious risk of fungal infections associated with drugs such as Simponi.
Currently there are no class action lawsuits on any court dockets, but there are many patients who due to the side effects they suffered from taking this drug have filed lawsuits against Johnson and Johnson.
If you think that you may have a possible lawsuit because you were prescribed this drug, and experienced any of the side effects that were listed above we would like to hear from you, so please contact us today.
AttorneyOne.com is a free nationwide legal referral service. We are not a law firm. We help consumers find the best representation for their legal needs.
If you or a loved one are in need of legal assistance concerning Simponi you should get a lawyer on your side immediately. You will pay no attorney fees unless you win your case.
Email up to 10 Simponi law firms in one click; by filling out the simple Free Case Evaluation form.
For additional info on Simponi use the practice area links on the far right.